Metraipolis › archive › dc_cf770563d798

Examining the immune response of participants receiving Modified Vaccinia Ankara vaccine in Africa (MpoxVax AFRIVAC): a prospective cohort study - protocol — Europe PMC PMID:42538105

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42538105
DOI
10.1136/bmjopen-2026-120064
License (as archived)
solo-consultazione
Archived
2026-10-08T15:15:32.689Z
SHA-256 of the archived text
404162f2f0965b049fd43be7b0683334deed43c3ee77718816735b0441d7196d
Stable URL of this page
https://metraipolis.com/documento/dc_cf770563d798

How to cite

Examining the immune response of participants receiving Modified Vaccinia Ankara vaccine in Africa (MpoxVax AFRIVAC): a prospective cohort study - protocol — Europe PMC PMID:42538105 — Europe PMC (en), https://europepmc.org/article/MED/42538105 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf770563d798 (Metraipolis archive dc_cf770563d798, sha256 404162f2f0965b049fd43be7b0683334deed43c3ee77718816735b0441d7196d)
BibTeX
@misc{dccf770563d798,
  title = {Examining the immune response of participants receiving Modified Vaccinia Ankara vaccine in Africa (MpoxVax AFRIVAC): a prospective cohort study - protocol — Europe PMC PMID:42538105},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42538105},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf770563d798; sha256 404162f2f0965b049fd43be7b0683334deed43c3ee77718816735b0441d7196d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42538105. Agents can read the archived copy with the MCP tool read_document.